Kwang-Hee Shin,
Kyu-Pyo Kim,
Kyoung Soo Lim,
Ji Who Kim,
Yun-Sang Lee, Bo Yeun Yang,
Jae Sung Lee,
Jae-Min Jung,
Seo-Hyun Yoon,
In-Jin Jang,
Kyung-Sang Yu
[show abstract]
[hide abstract]
ABSTRACT: This study explored microdosing methods for evaluating the distribution and pharmacokinetics (PK) of a central nervous system (CNS) drug candidate.
We used sertraline as a model drug. In this open-label, one-arm, three-period, multiple-dosing study, 10 healthy male volunteers received 6-day administrations of sertraline at doses of 5, 25 or 50 mg/d in three different periods. Before the first dose of Period 1, and 24 h after the last dose of each period, an intravenous bolus of [11C]sertraline was injected for positron emission tomography (PET) scanning. After the sixth dose in each period, serial blood samples were collected at scheduled intervals over 48 h; then serum sertraline concentrations were determined with liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Sertraline was distributed in the brain within 20 min, and it was highly distributed in the putamen, cingulate, and thalamus. Linearity in steady-state Cmax and AUClast were observed in the 5 - 50 mg dose range. The results suggested that microdosing with PET was a useful method for exploring the bloodbrain- barrier penetration and distribution of a candidate CNS drug.
This study described a microdosing method that combined PET with LC-MS/MS for determining the brain distribution and PK characteristics of a CNS drug candidate.
International journal of clinical pharmacology and therapeutics 03/2012; 50(3):224-32. · 1.18 Impact Factor
